South & Central America Transient Protein Expression Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2031 - Regional Analysis - by Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)

No. of Pages: 140    |    Report Code: TIPRE00022180    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Transient Protein Expression Market

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1           Hypothesis formulation:

3.2.2           Macro-economic factor analysis:

3.2.3           Developing base number:

3.2.4           Data Triangulation:

3.2.5           Country level data:

4.           South & Central America Transient Protein Expression Market – Key Market Dynamics

4.1       Market Drivers

4.1.1           Increasing Applications of Protein Expression Systems

4.1.2           Surging Popularity of Precision Medicine

4.2       Market Restraints

4.2.1           High Cost of Products

4.3       Market Opportunities

4.3.1           Plant-Based Expression Systems for Therapeutic Protein Production

4.4       Future Trends

4.4.1           Integration of Artificial Intelligence (AI) and Automation Technologies

4.5       Impact of Drivers and Restraints:

5.           Transient Protein Expression Market – South & Central America Analysis

5.1       South & Central America Transient Protein Expression Market Revenue (US$ Million), 2021–2031

5.2       South & Central America Transient Protein Expression Market Forecast Analysis

6.           South & Central America Transient Protein Expression Market Analysis – by Product Type

6.1       Instruments

6.1.1           Overview

6.1.2           Instruments: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

6.2       Reagents

6.2.1           Overview

6.2.2           Reagents: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

6.3       Expression Vectors

6.3.1           Overview

6.3.2           Expression Vectors: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

6.4       Competent Cells

6.4.1           Overview

6.4.2           Competent Cells: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.           South & Central America Transient Protein Expression Market Analysis – by Application

7.1       Genomic Research

7.1.1           Overview

7.1.2           Genomic Research: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.2       Gene Therapy

7.2.1           Overview

7.2.2           Gene Therapy: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.3       Bio production

7.3.1           Overview

7.3.2           Bio production: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.4       Cancer Research

7.4.1           Overview

7.4.2           Cancer Research: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.5       Drug Development

7.5.1           Overview

7.5.2           Drug Development: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

8.           South & Central America Transient Protein Expression Market Analysis – by End User

8.1       Pharmaceutical and Biotechnology Companies

8.1.1           Overview

8.1.2           Pharmaceutical and Biotechnology Companies: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

8.2       Academic and Research Institutes

8.2.1           Overview

8.2.2           Academic and Research Institutes: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031  (US$ Million)

8.3       Clinical Research Organizations

8.3.1           Overview

8.3.2           Clinical Research Organizations: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031  (US$ Million)

9.           South & Central America Transient Protein Expression Market – Country Analysis

9.1       South & Central America

9.1.1           South & Central America Transient Protein Expression Market Overview

9.1.2           South & Central America Transient Protein Expression Market – Revenue and Forecast Analysis – by Country

9.1.2.1        South & Central America Transient Protein Expression Market – Revenue and Forecast Analysis – by Country

9.1.2.2        Brazil: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.2.1        Brazil: South & Central America Transient Protein Expression Market Breakdown, by Product Type

9.1.2.2.2        Brazil: South & Central America Transient Protein Expression Market Breakdown, by Application

9.1.2.2.3        Brazil: South & Central America Transient Protein Expression Market Breakdown, by End User

9.1.2.3        Argentina: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.3.1        Argentina: South & Central America Transient Protein Expression Market Breakdown, by Product Type

9.1.2.3.2        Argentina: South & Central America Transient Protein Expression Market Breakdown, by Application

9.1.2.3.3        Argentina: South & Central America Transient Protein Expression Market Breakdown, by End User

9.1.2.4        Rest of South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.4.1        Rest of South & Central America Transient Protein Expression Market Breakdown, by Product Type

9.1.2.4.2        Rest of South & Central America Transient Protein Expression Market Breakdown, by Application

9.1.2.4.3        Rest of South & Central America Transient Protein Expression Market Breakdown, by End User

10.        Competitive Landscape

10.1     Company Positioning & Concentration

11.        Industry Landscape

11.1     Overview

11.2     Growth Strategies in South & Central America Transient Protein Expression Market

11.3     Organic Growth Strategies

11.3.1         Overview

11.4     Inorganic Growth Strategies

11.4.1         Overview

12.        Company Profiles

12.1     Thermo Fisher Scientific Inc

12.1.1         Key Facts

12.1.2         Business Description

12.1.3         Products and Services

12.1.4         Financial Overview

12.1.5         SWOT Analysis

12.1.6         Key Developments

12.2     Merck KGaA

12.2.1         Key Facts

12.2.2         Business Description

12.2.3         Products and Services

12.2.4         Financial Overview

12.2.5         SWOT Analysis

12.2.6         Key Developments

12.3     QIAGEN NV

12.3.1         Key Facts

12.3.2         Business Description

12.3.3         Products and Services

12.3.4         Financial Overview

12.3.5         SWOT Analysis

12.3.6         Key Developments

12.4     GenScript Biotech Corporation

12.4.1         Key Facts

12.4.2         Business Description

12.4.3         Products and Services

12.4.4         Financial Overview

12.4.5         SWOT Analysis

12.4.6         Key Developments

12.5     Promega Corp

12.5.1         Key Facts

12.5.2         Business Description

12.5.3         Products and Services

12.5.4         Financial Overview

12.5.5         SWOT Analysis

12.5.6         Key Developments

12.6     Takara Bio Inc

12.6.1         Key Facts

12.6.2         Business Description

12.6.3         Products and Services

12.6.4         Financial Overview

12.6.5         SWOT Analysis

12.6.6         Key Developments

12.7     New England Biolabs

12.7.1         Key Facts

12.7.2         Business Description

12.7.3         Products and Services

12.7.4         Financial Overview

12.7.5         SWOT Analysis

12.7.6         Key Developments

12.8     Agilent Technologies Inc

12.8.1         Key Facts

12.8.2         Business Description

12.8.3         Products and Services

12.8.4         Financial Overview

12.8.5         SWOT Analysis

12.8.6         Key Developments

12.9     Mirus Bio LLC

12.9.1         Key Facts

12.9.2         Business Description

12.9.3         Products and Services

12.9.4         Financial Overview

12.9.5         SWOT Analysis

12.9.6         Key Developments

12.10  Bio-Rad Laboratories Inc

12.10.1      Key Facts

12.10.2      Business Description

12.10.3      Products and Services

12.10.4      Financial Overview

12.10.5      SWOT Analysis

12.10.6      Key Developments

12.11  Lonza Group AG

12.11.1      Key Facts

12.11.2      Business Description

12.11.3      Products and Services

12.11.4      Financial Overview

12.11.5      SWOT Analysis

12.11.6      Key Developments

12.12  MaxCyte Inc

12.12.1      Key Facts

12.12.2      Business Description

12.12.3      Products and Services

12.12.4      Financial Overview

12.12.5      SWOT Analysis

12.12.6      Key Developments

13.        Appendix

13.1     About The Insight Partners

13.2     Glossary of Terms

 

List of Tables

Table 1.             South & Central America Transient Protein Expression Market Segmentation

Table 2.             South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Table 3.             South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type

Table 4.             South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 5.             South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 6.             South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Country

Table 7.             Brazil: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 8.             Brazil: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 9.             Brazil: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 10.          Argentina: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) –  by Product Type

Table 11.          Argentina: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 12.          Argentina: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 13.          Rest of South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 14.          Rest of South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 15.          Rest of South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 16.          Recent Organic Growth Strategies in South & Central America Transient Protein Expression Market

Table 17.          Recent Inorganic Growth Strategies in the South & Central America Transient Protein Expression Market

Table 18.          Glossary of Terms, Transiaent Protein Expression Market

 

List of Figures

Figure 1.           South & Central America Transient Protein Expression Market Segmentation, by Country

Figure 2.           South & Central America Transient Protein Expression Market – Key Market Dynamics

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           South & Central America Transient Protein Expression Market Revenue (US$ Million), 2021–2031

Figure 5.           South & Central America Transient Protein Expression Market Share (%) – by Product Type (2023 and 2031)

Figure 6.           Instruments: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7.           Reagents: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8.           Expression Vectors: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9.           Competent Cells: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10.        South & Central America Transient Protein Expression Market Share (%) – by Application (2023 and 2031)

Figure 11.        Genomic Research: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12.        Gene Therapy: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13.        Bio production: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14.        Cancer Research: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15.        Drug Development: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16.        South & Central America Transient Protein Expression Market Share (%) – by End User (2023 and 2031)

Figure 17.        Pharmaceutical and Biotechnology Companies: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18.        Academic and Research Institutes: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031  (US$ Million)

Figure 19.        Clinical Research Organizations: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031  (US$ Million)

Figure 20.        South & Central America Transient Protein Expression Market Breakdown, by Key Countries – Revenue (2023) (US$ Million)

Figure 21.        South & Central America Transient Protein Expression Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 22.        Brazil: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)

Figure 23.        Argentina: South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)

Figure 24.        Rest of South & Central America Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)

Figure 25.        Company Positioning & Concentration

Figure 26.        Growth Strategies in South & Central America Transient Protein Expression Market

The List of Companies - South & Central America Transient Protein Expression Market

  • Thermo Fisher Scientific Inc     
  • Merck KGaA                                      
  • QIAGEN NV                                          
  • GenScript Biotech Corporation     
  • Promega Corp                                     
  • Takara Bio Inc                                     
  • New England Biolabs             
  • Agilent Technologies Inc         
  • Mirus Bio LLC                                
  • Bio-Rad Laboratories Inc          
  • Lonza Group AG
  • MaxCyte Inc